Becky McCarver Featured on KATU Family Matters: What You're Not Eating is Bad

Jennifer Burrows, RN, has been chosen to serve as the chief executive of Providence Oregon.

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.

Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

Providence and Regence have reached an agreement to continue care delivery services together.

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

Providence Heart Institute welcomed patients and their families for the clinic’s third anniversary of its advanced heart failure clinic.